The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
this gero-protective space is not that tidy it's it's it's not like statins i really know exactly which enzyme is inhibited i have a perfect biomarker and i have tons of data and we can then make the calculation for a given individual on a risk-adjusted basis whether this makes sense or not very difficult to do that with the molecules we're talking about
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
as unsexy as the world of Diagnostics and biomarkers are and it is a very very unsexy world I mean this is not a place where people like investing money this is not a place where there's an enormous amount of capital being thrown at the problem
as unsexy as the world of Diagnostics and biomarkers are and it is a very very unsexy world I mean this is not a place where people like investing money this is not a place where there's an enormous amount of uh Capital being thrown at the problem